• Babik, Jennifer M.
• Shirley, Debbie-Ann
• Scott, Brian J.
• Reid, Michael
• Sapp, Sarah G. H.
• Belova, Aleksandra
• Rivera, Hilda N.
• Mcauliffe, Isabel
• Montgomery, Susan P.
• Yabsley, Michael J.
• Sircar, Anita D.
• Langelier, Charles
• Huskins, W. Charles
• Cunningham, Dennis
• Coulter, Katrina S.
• Chin-Hong, Peter
• Blumberg, Dean
• Abanyie, Francisca

Abstract

Baylisascaris procyonis, predominantly found in raccoons, is a ubiquitous roundworm found throughout North America. Although raccoons are typically asymptomatic when infected with the parasite, the larval form of Baylisascaris procyonis can result in fatal human disease or severe neurologic outcomes if not treated rapidly. In the United States, Baylisascaris procyonis is more commonly enzootic in raccoons in the midwestern and northeastern regions and along the West Coast (1). However, since 2002, infections have been documented in other states (Florida and Georgia) and regions (2). Baylisascariasis is not a nationally notifiable disease in the United States, and little is known about how commonly it occurs or the range of clinical disease in humans. Case reports of seven human baylisascariasis cases in the United States diagnosed by Baylisascaris procyonis immunoblot testing at CDC are described, including review of clinical history and laboratory data. Although all seven patients survived, approximately half were left with severe neurologic deficits. Prevention through close monitoring of children at play, frequent handwashing, and clearing of raccoon latrines (communal sites where raccoons defecate) are critical interventions in curbing Baylisascaris infections. Early treatment of suspected cases is critical to prevent permanent sequelae.

Topics

• impedance spectroscopy